BiondVax Pharmaceuticals ...

NASDAQ: BVXV · Real-Time Price · USD
1.36
0.01 (0.74%)
At close: Sep 06, 2023, 9:59 PM

BiondVax Pharmaceuticals Ratios and Metrics

Financials in ILS. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-50.66 -2.02
PEG Ratio
0.51 0.00
PS Ratio
n/a n/a
PB Ratio
-15.28 4.40
P/FCF Ratio
-3.32 -4.12
P/OCF Ratio
-3.7 -4.19
OCF/S Ratio
n/a n/a
Debt / Equity Ratio
-12.24 2.99
Quick Ratio
6.15 7.64
Current Ratio
6.15 7.64
Asset Turnover
n/a n/a
Interest Coverage
n/a -3.22
Return on Equity
0.30 -2.18
Return on Assets
-0.02 -0.51
Return on Invested Capital
-0.04 -0.48
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
n/a n/a
Net Profit Margin
n/a n/a
Pretax Profit Margin
n/a n/a
Operating Profit Margin
n/a n/a
FCF Margin
n/a n/a
EBITDA Margin
n/a n/a